Concurrent Validity, Cut-offs and Ability to Change of Patient-reported Outcome Measures for Rhinitis and Asthma in MASK-air

Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.

Citing Articles

Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air.

Bousquet J, Sousa-Pinto B, Anto J, Bedbrook A, Czarlewski W, Ansotegui I Clin Transl Allergy. 2024; 14(9):e12390.

PMID: 39313483 PMC: 11419846. DOI: 10.1002/clt2.12390.

References

Hojo M, Ohta K, Iikura M, Mizutani T, Hirashima J, Sugiyama H . Clinical usefulness of a guideline-based screening tool for the diagnosis of allergic rhinitis in asthmatics: the Self Assessment of Allergic Rhinitis and Asthma questionnaire. Respirology. 2013; 18(6):1016-21. DOI: 10.1111/resp.12116. View

Bousquet J, Agache I, Aliberti M, Angles R, Annesi-Maesano I, Anto J . Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). Allergy. 2017; 73(1):77-92. DOI: 10.1111/all.13218. View

Bousquet J, Bachert C, Canonica G, Mullol J, Van Cauwenberge P, Bindslev Jensen C . Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study. Allergy. 2009; 64(10):1516-1523. DOI: 10.1111/j.1398-9995.2009.02115.x. View

Bousquet J, Illario M, Farrell J, Batey N, Carriazo A, Malva J . The Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing. Transl Med UniSa. 2019; 19:66-81. PMC: 6581486. View

Devlin N, Brooks R . EQ-5D and the EuroQol Group: Past, Present and Future. Appl Health Econ Health Policy. 2017; 15(2):127-137. PMC: 5343080. DOI: 10.1007/s40258-017-0310-5. View

Vieira R, Sousa-Pinto B, Cardoso-Fernandes A, Jacome C, Portela D, Amaral R . Control of Allergic Rhinitis and Asthma Test: A systematic review of measurement properties and COSMIN analysis. Clin Transl Allergy. 2022; 12(9):e12194. PMC: 9510765. DOI: 10.1002/clt2.12194. View

Bousquet P, Combescure C, Klossek J, Daures J, Bousquet J . Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol. 2009; 123(6):1349-54. DOI: 10.1016/j.jaci.2009.02.033. View

Benfante A, Sousa-Pinto B, Pillitteri G, Battaglia S, Fonseca J, Bousquet J . Applicability of the MASK-Air App to Severe Asthma Treated with Biologic Molecules: A Pilot Study. Int J Mol Sci. 2022; 23(19). PMC: 9569460. DOI: 10.3390/ijms231911470. View

Bousquet J, Sousa-Pinto B, Shamji M, Anto J, Klimek L, Canonica G . Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study. Clin Exp Allergy. 2023; 53(8):854-861. DOI: 10.1111/cea.14318. View

10.

Sousa-Pinto B, Azevedo L, Sa-Sousa A, Vieira R, Amaral R, Klimek L . Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model. Clin Transl Allergy. 2022; 12(3):e12128. PMC: 8967259. DOI: 10.1002/clt2.12128. View

11.

Bousquet J, Samolinski B, Kaidashev I, Maurer M, Roche N, Sousa-Pinto B . UCRAID (Ukrainian Citizen and refugee electronic support in Respiratory diseases, Allergy, Immunology and Dermatology) action plan. Allergy. 2023; 78(10):2581-2595. DOI: 10.1111/all.15855. View

12.

Bousquet J, Dahl R, Khaltaev N . Global alliance against chronic respiratory diseases. Allergy. 2007; 62(3):216-23. DOI: 10.1111/j.1398-9995.2007.01307.x. View

13.

Sousa-Pinto B, Louis R, Anto J, Amaral R, Sa-Sousa A, Czarlewski W . Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study. Pulmonology. 2023; 31(1):2416869. DOI: 10.1016/j.pulmoe.2023.07.004. View

14.

Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T . MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy. 2011; 66(5):596-604. DOI: 10.1111/j.1398-9995.2010.02534.x. View

15.

Demoly P, Bousquet P, Mesbah K, Bousquet J, Devillier P . Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy. 2013; 43(8):881-8. DOI: 10.1111/cea.12121. View

16.

Bousquet J, Bedbrook A, Czarlewski W, Onorato G, Arnavielhe S, Laune D . Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019; 9:16. PMC: 6413444. DOI: 10.1186/s13601-019-0252-0. View

17.

Sousa-Pinto B, Sa-Sousa A, Vieira R, Amaral R, Pereira A, Anto J . Cutoff Values of MASK-air Patient-Reported Outcome Measures. J Allergy Clin Immunol Pract. 2022; 11(4):1281-1289.e5. DOI: 10.1016/j.jaip.2022.12.005. View

18.

Taborda-Barata L, Ventura M, Blain H, Brussino L, Kvedariene V, Larenas-Linneman D . MASK-air real-world data in respiratory allergy in old-age adults. Clin Transl Allergy. 2023; 13(1):e12216. PMC: 9842785. DOI: 10.1002/clt2.12216. View

19.

Devillier P, Bousquet J, Salvator H, Naline E, Grassin-Delyle S, De Beaumont O . In allergic rhinitis, work, classroom and activity impairments are weakly related to other outcome measures. Clin Exp Allergy. 2016; 46(11):1456-1464. DOI: 10.1111/cea.12801. View

20.

Bousquet J, Sousa-Pinto B, Anto J, Bedbrook A, Czarlewski W, Ansotegui I . Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air. Clin Transl Allergy. 2024; 14(9):e12390. PMC: 11419846. DOI: 10.1002/clt2.12390. View